Ultima Genomics Appoints Francisco De La Vega to Lead Germline Genomics
Ultima Genomics announced in a press release that Francisco De La Vega has joined the company as Vice President of Germline Genomics and Distinguished Scientific Fellow. He brings more than 25 years of experience in human genetics, computational biology, and bioinformatics.
De La Vega will lead Ultima’s efforts in inherited genome analysis to advance research in genetic diseases, population health, and personalized medicine. He previously held senior positions at Applied Biosystems, Fabric Genomics, Tempus AI, and Galatea Bio, contributing to major projects such as the 1000 Genomes Project and the International Cancer Genome Consortium.
Ultima stated that De La Vega’s appointment supports its strategy to expand germline genome sequencing applications using its UG200 instrument and Solaris 2.0 chemistry. His experience in developing genetic analysis technologies and bioinformatics tools will help the company enhance scalability and accuracy across research and clinical genomics initiatives.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Illumina Launches BioInsight Platform for Genomic Research
INmune Bio and QCi Apply Quantum Computing to XPro Research
Deep Longevity to Launch Accrua Telehealth Platform in US
Helix and Databricks Launch Genomic Research Workspace
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
Daily AI Brief: the AI news that matters, in your inbox.